Patients as partners in clinical trials – Survey results

Last updated: June 25, 2025

We collaborate with patients to characterize their clinical trials expectations and better understand their readiness for remote clinical trials.
This 11-question survey was co-developed with a patient advocate and administered online in December 2020:

Why do patients not participate in clinical trials?

Do clinical trial participants generally use digital solutions and enjoy it?

Do they prefer home-based, site-based, or hybrid trials?

Which elements improve their clinical trial experience?

Subscribe to our newsletter

Expanding investor confidence: The strategic value of Patient Reported Outcomes...

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

Turning experience into evidence: PROs in IBD clinical research

BYOD on the rise

Strategies to promote BYOD adoption by clinical study sites

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET

In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....